FI67415C - Foerfarande foer behandling av sulfatavlut - Google Patents

Foerfarande foer behandling av sulfatavlut Download PDF

Info

Publication number
FI67415C
FI67415C FI760344A FI760344A FI67415C FI 67415 C FI67415 C FI 67415C FI 760344 A FI760344 A FI 760344A FI 760344 A FI760344 A FI 760344A FI 67415 C FI67415 C FI 67415C
Authority
FI
Finland
Prior art keywords
sodium
stream
cooking
flow
liquor
Prior art date
Application number
FI760344A
Other languages
English (en)
Finnish (fi)
Other versions
FI760344A (ja
FI67415B (fi
Inventor
Howard B Lange
Original Assignee
Babcock & Wilcox Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Babcock & Wilcox Co filed Critical Babcock & Wilcox Co
Publication of FI760344A publication Critical patent/FI760344A/fi
Publication of FI67415B publication Critical patent/FI67415B/fi
Application granted granted Critical
Publication of FI67415C publication Critical patent/FI67415C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
FI760344A 1975-02-21 1976-02-12 Foerfarande foer behandling av sulfatavlut FI67415C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/551,811 US3934013A (en) 1975-02-21 1975-02-21 Pharmaceutical composition
US55181175 1975-02-21

Publications (3)

Publication Number Publication Date
FI760344A FI760344A (ja) 1976-08-22
FI67415B FI67415B (fi) 1984-11-30
FI67415C true FI67415C (fi) 1985-03-11

Family

ID=24202770

Family Applications (1)

Application Number Title Priority Date Filing Date
FI760344A FI67415C (fi) 1975-02-21 1976-02-12 Foerfarande foer behandling av sulfatavlut

Country Status (18)

Country Link
US (1) US3934013A (ja)
JP (1) JPS6135166B2 (ja)
AU (1) AU504748B2 (ja)
BE (1) BE838711A (ja)
BR (1) BR7600834A (ja)
CA (1) CA1067409A (ja)
DE (1) DE2605242A1 (ja)
DK (1) DK68876A (ja)
ES (1) ES445151A1 (ja)
FI (1) FI67415C (ja)
FR (1) FR2301262A1 (ja)
GB (1) GB1502544A (ja)
IE (1) IE43655B1 (ja)
IL (1) IL48797A (ja)
IT (1) IT1066085B (ja)
NL (1) NL7601667A (ja)
NZ (1) NZ180042A (ja)
ZA (1) ZA7671B (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
BE861876A (fr) * 1976-12-17 1978-06-15 Scherico Ltd Nouvelles formulations d'antibiotiques beta-lactame leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
US4780455A (en) * 1985-04-12 1988-10-25 The Trustees Of Columbia University In The City Of New York Lipophilic complexes of pharmacologically active organic compounds
US4792556A (en) 1985-09-09 1988-12-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DE3534743A1 (de) * 1985-09-28 1987-04-02 Beiersdorf Ag Hydrocortisondiester enthaltende o/w-creme
US4740372A (en) * 1986-09-17 1988-04-26 Ljubomir Boncic Composition for treating psoriasis vulgaris and a method for its preparation
US5171737A (en) * 1989-03-03 1992-12-15 The Liposome Company, Inc. Emulsions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
DE69427589T2 (de) * 1993-10-22 2002-04-25 Smithkline Beecham Corp Neue zusammensetzung
WO1996002254A1 (en) * 1994-07-15 1996-02-01 Michel Cohen SYNERGISTIC PHARMACEUTICAL COMPOSITONS CONTAINING 16'alpha',17'alpha'-ISOPROPYLIDENEDIOXY SUBSTITUTED PREGNANES
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
EP2309858A4 (en) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
EP2473161B1 (en) 2009-08-31 2017-05-17 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
PL2366408T3 (pl) 2010-03-01 2013-01-31 Salvat Lab Sa Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu
ES2857602T3 (es) 2014-03-11 2021-09-29 Promius Pharma Llc Composiciones tópicas de corticosteroides
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
PL409156A1 (pl) 2014-08-11 2016-02-15 Matonis Grzegorz Kompozycja kosmetyczna i/lub farmaceutyczna łagodząca objawy łuszczycy
EP3651753A4 (en) * 2017-07-11 2021-05-05 University Of Miami TOPICAL ACETAMINOPHEN FORMULATIONS FOR ITCH RELIEF
AU2021318201A1 (en) 2020-07-28 2023-02-02 Arcutis Biotherapeutics, Inc. Topical formulation containing jak inhibitor and laureth-4

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073743A (en) * 1959-07-30 1963-01-15 Upjohn Co Antiinflammatory steroid acetonide compositions and therapy
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides

Also Published As

Publication number Publication date
JPS51110043A (ja) 1976-09-29
AU1085876A (en) 1977-03-17
NZ180042A (en) 1978-07-28
AU504748B2 (en) 1979-10-25
IL48797A0 (en) 1976-03-31
FI760344A (ja) 1976-08-22
ZA7671B (en) 1977-08-31
BE838711A (fr) 1976-08-19
AU1068276A (en) 1977-08-04
IE43655L (en) 1976-08-21
IL48797A (en) 1979-01-31
IT1066085B (it) 1985-03-04
FI67415B (fi) 1984-11-30
JPS6135166B2 (ja) 1986-08-12
BR7600834A (pt) 1976-09-14
FR2301262A1 (fr) 1976-09-17
DK68876A (da) 1976-08-22
ES445151A1 (es) 1977-05-16
CA1067409A (en) 1979-12-04
DE2605242A1 (de) 1976-09-02
IE43655B1 (en) 1981-04-22
GB1502544A (en) 1978-03-01
FR2301262B1 (ja) 1979-04-06
NL7601667A (nl) 1976-08-24
US3934013A (en) 1976-01-20

Similar Documents

Publication Publication Date Title
FI67415C (fi) Foerfarande foer behandling av sulfatavlut
JP2684348B2 (ja) 黒液のガス化器
US6136144A (en) Method of removing sulfur from a process gas stream using a packed bed calcinator
FI82727C (fi) Foerfarande foer foergasning av svartlut.
RU2126863C1 (ru) Способ отделения серных соединений (варианты)
US3236589A (en) Method of working up cellulose waste liquor containing sodium and sulfur
US3574051A (en) Recovery of black liquor
RU2683338C2 (ru) Способ обработки черного щелока
US4004966A (en) Fume control for sulfur dioxide ammonia absorption systems
CA1089162A (en) Fluidized bed treatment of kraft black liquor with h.sub.2s absorption
AU658660B2 (en) Method and apparatus for separating molten particles from a stream of gas
FI71787C (fi) Foerfarande och anordning foer tillvaratagande av vaerme och kemikalier fraon avlutar fraon cellulosaframstaellning.
FI81142C (fi) Gasningsfoerfarande foer svartlut.
US5683550A (en) Method and apparatus for increasing recovery boiler capacity by withdrawing combustible gas from the furnace
CS209904B2 (en) Facility for regeneration of chemical substances from combustion products and green liquar
US5366716A (en) Method for recovering sulphur dioxide from the chemical circulation of a sulphate pulp mill
US3650889A (en) Pollution controlled polysulfide recovery process
JPH10504607A (ja) 黒液をガス化させることによって形成されたガスの洗浄法
BE845055A (fr) Production de la pate a papier
KR950002544B1 (ko) 음이온 성분-함유 화합물과 탄소성 물질을 함유하는 조성물 및 그의 환원연소 방법
US5855737A (en) Process for regenerating a liquid created in the kraft process for pulping wood, while simultaneously obtaining high energy efficiency
FI89518B (fi) Foerfarande foer aotervinning av svavel och alkali
FI123106B (fi) Menetelmä kemikaalien regeneroimiseksi sekä sähkön ja lämmön tuottamiseksi sellun ja kemiallismekaanisen massan valmistuksen jäteliemestä
WO1998055685A1 (en) System and method for paper mill sulfur recovery and odor control
NO762515L (no) Fremgangsm}te ved massekoking.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: THE BABCOCK & WILCOX CO.